Efficient synthesis of 1, 3, 4-oxadiazoles promoted by NH4Cl KK Gnanasekaran, B Nammalwar, M Murie, RA Bunce Tetrahedron letters 55 (50), 6776-6778, 2014 | 35 | 2014 |
Small Molecule Inhibitors of the BfrB–Bfd Interaction Decrease Pseudomonas aeruginosa Fitness and Potentiate Fluoroquinolone Activity AND Punchi Hewage, H Yao, B Nammalwar, KK Gnanasekaran, S Lovell, ... Journal of the American Chemical Society 141 (20), 8171-8184, 2019 | 23 | 2019 |
Benzo [4, 5] imidazo [2, 1-b] quinazolin-12-ones and benzo [4, 5] imidazo [1, 2-a] pyrido [2, 3-d] pyrimidin-5-ones by a sequential N-acylation–SNAr reaction KK Gnanasekaran, NP Muddala, RA Bunce Tetrahedron letters 56 (52), 7180-7183, 2015 | 20 | 2015 |
Synthesis and evaluation of second generation Flex-Het scaffolds against the human ovarian cancer A2780 cell line KK Gnanasekaran, DM Benbrook, B Nammalwar, E Thavathiru, RA Bunce, ... European Journal of Medicinal Chemistry 96, 209-217, 2015 | 19 | 2015 |
Alkyl-and aryl-substituted benzo [ghi] perylenetriimides: Synthesis, characterization and comparison of electrochemical and spectroscopic properties LCK Viswanath, J Bernhardt, KK Gnanasekaran, C Want, J Frank, ... Dyes and Pigments 134, 453-458, 2016 | 13 | 2016 |
Syntheses of 1-Aryl-5-nitro-1H-indazoles and a General One-Pot Route to 1-Aryl-1H-indazoles JK Annor-Gyamfi, KK Gnanasekaran, RA Bunce Molecules 23 (3), 674, 2018 | 12 | 2018 |
Bismuth (III) triflate catalyzed tandem esterification–Fries–oxa-Michael route to 4-chromanones K Meraz, KK Gnanasekaran, R Thing, RA Bunce Tetrahedron Letters 57 (46), 5057-5061, 2016 | 12 | 2016 |
Pyrazoloquinazolinones and pyrazolopyridopyrimidinones by a sequential N-acylation–SNAr reaction KK Gnanasekaran, NP Muddala, RA Bunce Tetrahedron letters 56 (11), 1367-1369, 2015 | 12 | 2015 |
Isoquinolin-1 (2H)-ones and 1, 6-naphthyridin-5 (6H)-ones by an N-acylation-SNAr sequence RA Bunce, B Nammalwar, KK Gnanasekaran, NR Cain Tetrahedron 70 (4), 838-844, 2014 | 9 | 2014 |
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells KK Gnanasekaran, T Pouland, RA Bunce, KD Berlin, S Abuskhuna, ... Bioorganic & Medicinal Chemistry 28 (1), 115244, 2020 | 8 | 2020 |
Nucleophilic additions to polarized vinylarenes KK Gnanasekaran, J Yoon, RA Bunce Tetrahedron Letters 57 (29), 3190-3193, 2016 | 5 | 2016 |
4, 7-Diaminoisoindoline-1, 3-dione KK Gnanasekaran, M Rivera, RA Bunce Organic preparations and procedures international 50 (3), 372-374, 2018 | 1 | 2018 |
Stat inhibitory compounds and compositions R Fleck, J Proudfoot, J Omeara, KK Gnanasekaran, PT Gunning, AA John, ... US Patent App. 17/909,153, 2023 | | 2023 |
Cannabigerol derivatives and use thereof as cannabinoid receptor modulators S Ahmar, KK Gnanasekaran, JA Omeara US Patent App. 17/780,047, 2023 | | 2023 |
Heterocycle containing stat inhibitors and compositions R Fleck, J Proudfoot, KK Gnanasekaran, PT Gunning, AA John, ... US Patent App. 17/909,162, 2023 | | 2023 |
Cannabinoid derivatives S Ahmar, KK Gnanasekaran, JA Omeara, JS Park US Patent App. 17/626,519, 2023 | | 2023 |
Use of small molecule inhibitors of the bfrb: bfd interaction in biofilms M Rivera, YAO Huili, RA Bunce, B Nammalwar, KK Gnanasekaran, ... US Patent App. 17/502,975, 2022 | | 2022 |
Small molecule inhibitors of the bfrb: bfd interaction M Rivera, YAO Huili, RA Bunce, B Nammalwar, KK Gnanasekaran, ... US Patent App. 17/299,267, 2022 | | 2022 |
Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents KD Berlin, RA Bunce, KK Gnanasekaran, FM Watts Jr, DH Zhou US Patent App. 17/167,251, 2021 | | 2021 |
Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents KK Gnanasekaran, KD Berlin, FM Watts Jr, D Zhou, RA Bunce US Patent and Trademark Office, 2021 | | 2021 |